Abstract
Get full access to this article
View all access options for this article.
References
1.
Reiter
T
,
McQuade
R
. Ind Biotechnol , 2011 ; 7 ,4 :272 –275 .
2.
Dhavan
G
,
Hudson
I
,
Fasse
JP
. Ind Biotechnol , 2012 ; 8 ,2 :107 –109 .
3.Mayo Collaborative Services, DBA Mayo Medical Laboratories et al. v. Prometheus Laboratories, Inc. 566 U.S.2012 .
4.
Id. at 5–6.
5.
Id. at 3.
6.
Id. at 4.
7.
Id. at 10.
8.
Id. at 3.
9.
Id. at 9.
10.
Id. at 10.
11.
Id. at 9.
12.
Id. at 10.
13.Association for Molecular Pathology et al., v. Myriad Genetics, Inc. al. 689 F.3d 13032012 .
14.PerkinElmer, Inc., v. Intema Ltd. 496 Fed. Appx. 652012 .
15.
Id. at 1334.
16.
Id. at 1335.
17.
Id. at 1336.
18.
Id. at 1336.
19.Association for Molecular Pathology et al. v. Myriad Genetics, Inc. et al. S.Ct., No. 12-3982013 .
20.
Id. at 1.
21.
Id. at 5.
22.
Id. at 5.
23.
Id. at 5.
24.
Id. at 7 (internal quotations removed).
25.
Id. at 6.
26.
Id. at 6.
27.
Id. at 6.
28.
Id. at 1309.
29.
Id. at 1325.
30.
Id. at 3127 (internal citation removed; emphasis added).
31.
Id. at 1327.
32.
Id. at 1325.
33.
Id. at 1327.
34.Transcript of oral arguments in Association for Molecular Pathology et al. v. Myriad Genetics, Inc. et al. S.Ct., No. 12-3988 .
35.
Id. at 61.
36.
Id. at 17.
37.
Id. at 11.
38.
Id. at 12.
39.
Id. at 28–29.
40.
Id. at 29.